Today: 19 April 2026
Glencore share price: Rio Tinto clock and Canada smelter talks set up the week ahead
1 February 2026
1 min read

Glencore share price: Rio Tinto clock and Canada smelter talks set up the week ahead

London, February 1, 2026, 07:53 GMT — Market closed.

  • Glencore closed Friday at 499.25 pence, down 1.7%.
  • Bloomberg reported Rio and Glencore may seek more time for merger talks ahead of Feb. 5.
  • Glencore Canada said key issues remain unresolved in talks on the Horne smelter’s future.

Glencore Plc (GLEN.L) closed down 1.7% at 499.25 pence on Friday, with investors heading into the new week watching the takeover timetable and a regulatory standoff in Canada.

On Friday, Bloomberg reported Rio and Glencore were expected to seek an extension from the UK’s mergers regulator to keep talks going, citing people familiar with the matter. The report said valuation issues were still a sticking point.

Glencore Canada said it was still in discussions with authorities in Quebec over a “viable path forward” for its Horne Smelter and the Canadian Copper Refinery, after flagging Jan. 31 as a deadline to confirm long-term operating conditions. “Certain key elements remain unresolved,” it said, adding the required work would involve “several hundred million dollars” of investment. Newswire

Under the UK Takeover Code, the clock pushes the bidder to declare a firm offer or walk away by a set time, unless the Takeover Panel agrees to an extension. Glencore said the cut-off for Rio is 5 p.m. London time on Feb. 5.

Position disclosures linked to the “offer period” have continued to hit the tape. A London Stock Exchange filing showed Geode Capital Management, LLC held 108.9 million Glencore shares, about 0.93%, as of Jan. 29 — the type of Form 8.3 notice required when a holder is at 1% or more during takeover talks. Investegate

Glencore’s latest operating snapshot — its full-year production report — pointed to a softer year for copper but a sharp second-half recovery. Chief Executive Officer Gary Nagle said production stayed within guidance and marketing adjusted EBIT (earnings before interest and tax, with some items stripped out) should come in around the mid-point of its $2.3 billion to $3.5 billion range. The company said 2025 copper production fell 11% to 851,600 tonnes, with 2026 guidance of 810,000-870,000 tonnes, and it flagged prioritising copper over cobalt under export quotas in the Democratic Republic of Congo.

But the week’s headline risk cuts both ways. A deadline extension is not a deal, and any breakdown on valuation — or on the Quebec talks — could quickly reprice the stock.

Traders will also watch for further takeover-related disclosures as big holders adjust around the timetable, and for any signal on what comes after the Jan. 31 marker in Quebec.

Beyond the deal noise, Glencore’s shares tend to track the pull of copper and coal prices, leaving it exposed to sharp swings in metals markets when London trading restarts.

The next tests are any timetable update from the regulator and Glencore’s preliminary annual results due on Feb. 18.

Stock Market Today

  • Wipro Limited Earnings Steady; Analysts Trim Price Target to ₹210 Post-Results
    April 18, 2026, 10:56 PM EDT. Wipro Limited's latest earnings report showed revenues of ₹926 billion and earnings per share (EPS) of ₹12.56, meeting analyst expectations. Following the results, 38 analysts forecast a revenue increase of 7.2% to ₹993.4 billion and an EPS rise of 8.8% to ₹13.70 by 2027. Despite stable earnings projections, the consensus price target for Wipro shares dropped by 5.4% to ₹210, reflecting tempered optimism. The demand outlook appears positive with expected revenue growth outpacing the company's five-year average and industry peers, indicating stronger momentum. Analyst valuations range between ₹170 and ₹255, signaling some variation but overall confidence in Wipro's growth trajectory.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Temasek cuts iFAST stake below 5% — what to watch for AIY share price as SGX reopens
Previous Story

Temasek cuts iFAST stake below 5% — what to watch for AIY share price as SGX reopens

Lloyds share price hits a 2026 high as buyback starts — what to watch before Monday
Next Story

Lloyds share price hits a 2026 high as buyback starts — what to watch before Monday

Go toTop